SCHEMBL17032011

SCHEMBL17032011

CN1C(=O)c2ccc3c4c(ccc(c24)C1=O)CC3

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.54
KDM4E B2RXH2 7/20 0.54
HPGD P15428 6/20 0.54
POLB P06746 5/20 0.54
TDP1 Q9NUW8 4/20 0.54
CYP1A2 P05177 2/20 0.54
CYP2C19 P33261 2/20 0.54
KMT2A Q03164 6/20 0.49
MEN1 O00255 5/20 0.49
MAPT P10636 3/20 0.49
RECQL P46063 2/20 0.49
ALOX15 P16050 2/20 0.49
HSD17B10 Q99714 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
PTPN7 P35236 1/20 0.49
BLM P54132 1/20 0.49
CACNA1B Q00975 1/20 0.49
APBA1 Q02410 1/20 0.49
PTK2B Q14289 1/20 0.49
LMNA P02545 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL127059 0.84 MEN1 (0.55) ALDH1A1KDM4EHPGDPOLBKMT2A
SCHEMBL30937815 0.84 MEN1 (0.55) ALDH1A1KDM4EHPGDPOLBKMT2A
SCHEMBL13285362 0.78 MEN1 (0.50) ALDH1A1KDM4EHPGDPOLBKMT2A
SCHEMBL13395554 0.77 MEN1 (0.46) ALDH1A1KDM4EHPGDPOLBKMT2A
SCHEMBL12170761 0.76 TERT (0.56) ALDH1A1KDM4EHPGDPOLBKMT2A
SCHEMBL710594 0.76 TERT (0.56) ALDH1A1KDM4EHPGDPOLBKMT2A
SCHEMBL9968962 0.76 TERT (0.56) ALDH1A1KDM4EHPGDPOLBKMT2A
SCHEMBL9968958 0.76 TERT (0.56) ALDH1A1KDM4EHPGDPOLBKMT2A
SCHEMBL29355182 0.76 TERT (0.56) ALDH1A1KDM4EHPGDPOLBKMT2A
SCHEMBL10048344 0.75 CES1 (0.48) ALDH1A1KDM4EHPGDPOLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9508937-B2 Acenaphthylene imide-derived semiconductors UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) 2016-11-29 US disclosed
US-9508937-B2 Acenaphthylene imide-derived semiconductors UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) 2016-11-29 US disclosed
US-20150243906-A1 ACENAPHTHYLENE IMIDE-DERIVED SEMICONDUCTORS UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) 2015-08-27 US disclosed
US-20150243906-A1 ACENAPHTHYLENE IMIDE-DERIVED SEMICONDUCTORS UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243906-A1 ACENAPHTHYLENE IMIDE-DERIVED SEMICONDUCTORS ACE, ACE2, AQP4 ALDH1A1 3648/4885KDM4E 2956/4885HPGD 3663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.